We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. OK, I agree | Cookies Policy

APROTECOL® Drops

0

Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview

Núria Piqué, María del Carmen Gómez-Guillén and María Pilar Montero

Disruption of the epithelial barrier function has been recently associated with a variety of diseases, mainly at intestinal level, but also affecting the respiratory epithelium and other mucosal barriers. Non-pharmacological approaches such as xyloglucan, with demonstrated protective barrier properties, are proposed as new alternatives for the management of a wide range of diseases, for which mucosal disruption and, particularly, tight junction alterations, is a common characteristic.

Read more

Aprotecol® drops Launched In Italy

We are pleased to announce the launch of APROTECOL® drops, our product for reducing the symptoms of infant colic, in Italy. The product is distributed by Pierre Fabre. Aprotecol® drops is a Class IIa CE marked medical device intended for the treatment of meteorism, aerophagy and flatulent colic in infants and children. Aprotecol® has been available as drops for oral administration in pharmacies and presented to pediatricians all across Italy since the beginning of January. Aprotecol® drops is a class IIa medical device and complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments. (CE 0476, Noventure SL)

Read more

Let's meet in..

2018, May 26

EAACI 2018

Read more

2018, May 28

PharmaVenue May 2018

Read more

2018, Jun 11

EuroPLX 67

Read more

2018, Aug 29

FNM 2018

FNM-2018-Amsterdam
Read more

2018, Oct 24

UEG Week 2018

Read more